Elevated β-catenin and C-myc promote malignancy, relapse, and indicate poor prognosis in patients with relapsed glioma

MLA

Dexiang Wang, et al. “Elevated β-Catenin and C-Myc Promote Malignancy, Relapse, and Indicate Poor Prognosis in Patients with Relapsed Glioma.” Journal of Cancer Research and Therapeutics, vol. 18, no. 2, June 2022. EBSCOhost, widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.doi.dedup.....7e9ef47a71f180f3f3fa73fddbcf19f5&authtype=sso&custid=ns315887.

APA

Dexiang Wang, Xuejuan Yu, Fengxia Xiao, Yuzhen Wei, Lifeng Miao, Wei Zhang, & Xin Zhang. (2022). Elevated β-catenin and C-myc promote malignancy, relapse, and indicate poor prognosis in patients with relapsed glioma. Journal of Cancer Research and Therapeutics, 18(2).

Chicago

Dexiang Wang, Xuejuan Yu, Fengxia Xiao, Yuzhen Wei, Lifeng Miao, Wei Zhang, and Xin Zhang. 2022. “Elevated β-Catenin and C-Myc Promote Malignancy, Relapse, and Indicate Poor Prognosis in Patients with Relapsed Glioma.” Journal of Cancer Research and Therapeutics 18 (2). http://widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.doi.dedup.....7e9ef47a71f180f3f3fa73fddbcf19f5&authtype=sso&custid=ns315887.